// App-Quantinova.ai

OC14.01 : *Pre-eclampsia screening in Denmark (PRESIDE): a national implementation study

Researchers

Presenter

  • I. Riishede

Principal Investigators

  • L. Rode

  • P. Sandager

  • S. Wagner

  • K. Pihl

  • F.S. Joergensen

  • H.J. Zingenberg

  • P. Nørgaard

  • L. Sperling

  • M. Overgaard

  • D. Wright

  • A. Wright

  • A. Tabor

  • C.K. Ekelund

Medical Centers

  • Aarhus University Hospital, Aarhus, Denmark

  • Odense University Hospital, Odense, Denmark

  • University of Exeter Institute of Health Research, Exeter, United Kingdom

  • Department of Fetal Medicine, Herlev Hospital, Herlev, Denmark

  • Department of Fetal Medicine, Nordsjaellands Hospital, Hillerod, Denmark

  • Copenhagen University Hospital, Copenhagen, Denmark

Locations

  • Denmark

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Preeclampsia

Biomarkers

  • Pregnancy-associated plasma protein A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final